Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Search Posts
Newsletter
Cap and Trade, GM’s Bankruptcy and Whole Foods’ Woes
Democrats formally unveil a 932-page bill to restrict greenhouse gas emissions. General Motor Corp.’s proposed bankruptcy filing pits union retirees against GM investors. Profits for…
Citation
FDA Drug approval delays; new drug called Provenge
Newsletter
Healthy Eating, Big Labor Fights Itself and the War on Mining
A new Food and Drug Administration study sparks debate over the health benefits of eating fish. Factions of the labor union known as UNITE-HERE fight…
Newsletter
Celebrating Earth Day, the FDA Drags Its Feet and Health Scares Debunked
CEI releases a new video titled “Humans Make Earth Day Better.” Promising anti-cancer drug Provenge languishes in the federal approval process despite mounting evidence of…
Comment
CEI Comments on Draft FDA Risk-Benefit Assessment of Fish Consumption
CEI applauds the FDA's even-handed approach.
News Release
Good News, But Prostate Cancer Patients Still Waiting
Sunday’s meeting of the American Association of Cancer Research saw new hope for prostate cancer patients, as researchers announced very favorable results for the drug…